Webinar
Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance
Available On Demand
Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique Marsh—Associate Director and Co-Head of Trinity’s Marketing Communications Insights COE, Julie Bayley—Associate Director in Trinity’s Insights practice and Ari King, Associate Consultant.
Key Topics
- What initiatives are being undertaken at the corporate level to improve trial diversity?
- How effective are these initiatives?
- What impact will the FDA’s guidance have on diversity now and in the future?
In Case You Missed It
Click here to read our white paper entitled Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance.
